Investors

Kalium Agri, the parent company of Oxyntra, is a patent-pending breakthrough that improves herd health, increases milk yields, and reduces methane—delivering ROI for farmers and investors alike.

Invest in the Future of Sustainable Dairy.

Why Invest?

To produce Oxyntra, we use an organic, chelated magnesium built into the manufacturing process, creating a mineral complex that prevents the known magnesium–potassium conflict in dairy cows and improves absorption of both nutrients unlocking butyrate production providing many health benefits.

Problem

Traditional supplements leave cows deficient and farmers struggling with health, yield, and environmental costs.

Solution

Oxyntra unlocks butyrate, optimizes magnesium absorption, and reduces oxidative stress—delivering measurable results.

Proof

Patent-pending technology, successful R&D, 60,000 lbs manufactured, backed by leading dairy researchers.

Why Invest?

TAM (Total Addressable Market)

9.3M dairy cows in the U.S. + International Markets

SAM (Initial Target)

5% gain → thousands in savings per herd

Adoption Drivers

Rising demand for fat/protein, sustainability pressures, and farm profitability.

Business Model

Contact Our Team

Phase 1

R&D & pilot (completed)

Phase 2

Commercial launch (Spring 2026)

Phase 3

Expansion (Southwest, West, International)

Approach

Asset-light toll manufacturing + distribution partnerships.

Sales Focus

Nutrition consultants, large dairies, strategic partnerships

Join Us in Building the Future of Dairy.

Investor Deck

Contact Us

The next generation of dairy nutrition is here.

Follow us